Wedgewood’s Extensive Compounded Formulary Now Available on the Blue Rabbit Home Delivery Platform
May 02 2024 - 2:16PM
Business Wire
Since its strategic merger with Blue Rabbit in June 2023,
Wedgewood has evolved its position as the nation’s leading
veterinary compounding pharmacy to become a comprehensive
veterinary pharmacy solutions provider. Today, the combined company
announces the full integration of Wedgewood’s extensive compounded
formulary on the Blue Rabbit home delivery platform, marking a
significant milestone in the merger.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240502421421/en/
(Graphic: Business Wire)
Blue Rabbit launched in January and has become a cornerstone of
Wedgewood’s offering. The platform provides veterinarians with a
white-labeled online storefront that now includes Wedgewood’s vast
formulary of compounded medications, as well as commercial
medications, pet food, preventatives, and supplements—all
integrated with the practice PIMS and delivered to animal owners’
homes with just a few clicks. Blue Rabbit also helps veterinarians
compete with online pet stores by bringing their own clients an
exceptional and convenient shopping and delivery experience.
Antoinette Osswald, office manager at Reidville Road Animal
Hospital, stated, “We have had awesome customer service through the
whole transition process. We have used previous online
pharmacies in the past but none compare to the ease and
professionalism of Blue Rabbit. Our clients also find it easier to
navigate.”
Wedgewood’s CEO, Marcy Bliss, stated: "Veterinarians told us
they needed a home delivery platform that would allow them to
easily and quickly prescribe and deliver comprehensive care to
their patients—including commercial medications, diets,
supplements, and, of course, Wedgewood’s trusted compounds. We
merged with Blue Rabbit last year to bring such a platform to the
market. Now, everything a veterinarian needs to ensure their
patients receive the medications and diets that meet their unique
needs is at their fingertips all on one platform.”
By adding Wedgewood’s compounds to the Blue Rabbit platform,
veterinarians and their clients gain access to compounds with
extended Beyond-Use Dates (BUDs), thanks to strategic investments
Wedgewood made in anticipation of the United States Pharmacopeia
(USP) changes that went into effect on November 1, 2023. The new
USP standards significantly reduced the BUDs of many compounded
medications unless they went through extensive testing.
Understanding the challenges these changes would pose for
veterinarians and their patients, Wedgewood invested in a 503B
outsourcing facility in 2020 (operating under FDA registration and
cGMP standards), acquired its own private analytical testing
laboratory, and conducted stability and sterility tests that allow
them to assign the longest possible BUDs in compliance with the new
standards.
Veterinarians are invited to discover the benefits of Blue
Rabbit and Wedgewood through a free 30-minute demo to learn how
this platform can boost practice profitability and enhance patient
care.
Schedule a demo [HERE] to see how Blue Rabbit
and Wedgewood can help drive optimal outcomes for your patients and
your practice. Learn more at BlueRabbit.vet.
Wedgewood is the nation’s largest and most trusted provider of
compounded veterinary medication and clinical pharmacy services.
Its recent merger with Blue Rabbit enables the company to provide
veterinarians with a next-generation platform to streamline patient
care and marks a significant evolution in services. Together Blue
Rabbit and Wedgewood serve more than 70,000 veterinary
professionals and over one million animals annually.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240502421421/en/
For additional information, contact Meg Thomann, Director of
Communications, mthomann@wedgewoodpharmacy.com